Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
CapsoVision, Inc (CV)
Standardized SEC financial data for CapsoVision, Inc — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001378325 · NASDAQ · Electromedical & Electrotherapeutic Apparatus.
Gross margin
52.9%
Operating margin
-188.3%
Net margin
-186.8%
Revenue growth (YoY)
15.3%
Return on equity
-190.9%
Free cash flow
-$23.0M
Current ratio
3.77×
EPS (diluted)
$-1.03
Ratios for fiscal year 2025, standardized from SEC filings.